![Oculis raises an additional $15M in funding before going public](/content/images/size/w720/wordpress/2023/02/82161-2.jpg)
Oculis raises an additional $15M in funding before going public
The Iceland-founded biopharmaceutical company Oculis which is purposefully driven to save sight and improve eye care with innovations has raised $15M as first reported by Viðskiptablaðið. The participating investors in this newly secured funding round are from Iceland and abroad. This funding adds to the $80M that the company raised